Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TOVX stock hub

Theriva Biologics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TOVXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.2M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

TOVX

In the news

Latest news · TOVX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-138.9

P25 -105.6P50 -46.5P75 -3.1

ROIC-42.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TOVX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

194

Groups with data

Currency

USD

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000894158
Company name	Theriva Biologics, Inc.
Country	United States
Country code	US
Cusip	87164U508
Employees	16
Employees Change	-6%
Employees Change Percent	-27.27
Enterprise value	$5.5M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2006-06-26
Isin	US87164U5083
Last refreshed	2026-05-10
Market cap	$16.2M
Market cap category	Nano-Cap
Price	$0.35
Price currency	USD
Rev Per Employee	18,750x
Sector	Healthcare
Sic	2834
Symbol	TOVX
Website	https://therivabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-141.38%
EV/Sales	18.36x
FCF yield	-88.66%
P/B ratio	1.06x
P/S ratio	54.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$300,000
Net Income	$-23M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Pretax Margin	-7,153%
Profit Per Employee	$-1.4M
ROA	-22.6
Roa5y	-22.54
ROCE	-45.49
ROE	-138.9
Roe5y	-67.45
ROIC	-42.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-66.49%
Cagr15y	-49.02%
Cagr1y	-56.32%
Cagr3y	-73.18%
Cagr5y	-69.29%
EPS Growth Quarters	1
EPS Growth Years	10
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$38.2M
Cash	$14.4M
Current Assets	$16.8M
Current Liabilities	$10.3M
Debt	$3.7M
Debt Equity	$0.24
Equity	$15.4M
Liabilities	$22.8M
Long Term Assets	$21.5M
Long Term Liabilities	$12.6M
Net Cash	$10.7M
Net Cash By Market Cap	$66.1
Net Cash Growth	49.99%
Net Debt Equity	$-0.7
Tangible Book Value	$15.4M
Tangible Book Value Per Share	$0.34
WACC	8.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.63
Net Working Capital	$-7.4M
Quick ratio	1.57
Working Capital	$6.5M
Working Capital Turnover	$0.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1,059.74%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-56.3%
200-day SMA	0.3
3Y total return	-98.07%
50-day SMA	0.26
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.73%
All Time High	262,502.3
All Time High Change	-100%
All Time High Date	2007-01-04
All Time Low	0.16
All Time Low Change	117.44%
All Time Low Date	2026-02-23
ATR	0.04
Beta	1.17
Beta1y	1.78
Beta2y	1.27
Ch YTD	68.25
High	0.36
High52	0.86
High52 Date	2025-10-15
High52ch	-58.99%
Low	0.34
Low52	0.16
Low52 Date	2026-02-23
Low52ch	117.45%
Ma50ch	36.63%
Premarket Change Percent	-1.94
Premarket Price	$0.35
Premarket Volume	257,267
Price vs 200-day SMA	18.75%
RSI	56.37
RSI Monthly	30
RSI Weekly	54.95
Sharpe ratio	0.16x
Sortino ratio	0.33
Total Return	-1,059.74%
Tr YTD	68.25
Tr15y	-100%
Tr1m	41.88%
Tr1w	-9.14%
Tr3m	60.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.05
Operating Income	$-12.7M
Operating margin	-4,243.3
Price target	$1
Price Target Change	$182

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45,143,431%
Float Percent	98.37%
Net Borrowing	43,000
Shares Insiders	1.63%
Shares Institutions	3.63%
Shares Out	45,892,668
Shares Qo Q	40.3%
Shares Yo Y	1,059.74%
Short Float	5.64%
Short Ratio	0.14
Short Shares	5.54

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-15.1M
Average Volume	39,031,761.05x
Bv Per Share	0.34
CAPEX	$-35,000
Ch10y	-100
Ch15y	-100
Ch1m	41.88
Ch1w	-9.14
Ch1y	-56.3
Ch3m	60.91
Ch3y	-98.07
Ch5y	-99.73
Ch6m	27.71
Change	-1.67%
Change From Open	-0.84
Close	0.36
Days Gap	-0.83
Depreciation Amortization	106,000
Dollar Volume	438,855.2
Earnings Date	2026-05-05
Earnings Time	amc
EBIT	$-12.7M
EBITDA	$-12.6M
EPS	$-1.06
F Score	2
FCF	$-14.4M
FCF EV Yield	-261.51x
FCF Per Share	$-0.31
Financing CF	18,987,000
Fiscal Year End	December
Founded	2,001
Investing CF	-35,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2024-08-26
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	0.26
Ma150ch	37.32%
Ma20	0.34
Ma20ch	4.3%
Net CF	4,362,000
Open	0.36
Optionable	No
Position In Range	78.57
Ppne	2,140,000
Pre Close	0.36
Price Date	2026-05-08
Ptbv Ratio	1.06
Relative Volume	0.03x
Revenue	300,000x
SBC By Revenue	229.67x
Share Based Comp	689,000
Tr6m	27.71%
Us State	Maryland
Volume	1,239,704

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TOVX pay a dividend?

Capital-return profile for this ticker.

Performance

TOVX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TOVX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.6%

Float: +98.4% of shares outstanding

Insider ownership

+1.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TOVX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.4

Neutral momentum band

Price vs 200-day MA

+18.8%

50/200-day relationship not available

Beta (5Y)

1.17

Moves roughly with the market

Sharpe ratio

0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TOVX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TOVX stock rating?

Theriva Biologics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TOVX analysis?

The full report lives at /stocks/TOVX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TOVX?

The latest report frames TOVX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TOVX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.